PlainRecalls
FDA Devices Moderate Class II Terminated

MYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission of results by transferring, storing, and displaying medical device data.

Reported: August 18, 2021 Initiated: June 22, 2021 #Z-2225-2021

Product Description

MYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission of results by transferring, storing, and displaying medical device data.

Reason for Recall

Software anomaly - Under certain conditions, unwanted alterations to results could be applied when using the BCI Connect scripting feature.

Details

Recalling Firm
BioMerieux SA
Units Affected
248 systems
Distribution
Distribution in the U.S. was nationwide. There was also military and government distribution.
Location
Marcy L'Etoile, N/A

Frequently Asked Questions

What product was recalled?
MYLA software. Used to manage microbiology test workflow from the reception of requests to the transmission of results by transferring, storing, and displaying medical device data.. Recalled by BioMerieux SA. Units affected: 248 systems.
Why was this product recalled?
Software anomaly - Under certain conditions, unwanted alterations to results could be applied when using the BCI Connect scripting feature.
Which agency issued this recall?
This recall was issued by the FDA Devices on August 18, 2021. Severity: Moderate. Recall number: Z-2225-2021.